These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 31810139)

  • 1. WSZG inhibits BMSC-induced EMT and bone metastasis in breast cancer by regulating TGF-β1/Smads signaling.
    Ma J; Li J; Wang Y; Chen W; Zheng P; Chen Y; Sun Z; Liu J; Zhou Y; Wang J; Liu S; Han X
    Biomed Pharmacother; 2020 Jan; 121():109617. PubMed ID: 31810139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1/Notch, TGF-β and IL-6 signaling pathways.
    Wu C; Chen M; Sun Z; Ye Y; Han X; Qin Y; Liu S
    J Ethnopharmacol; 2019 Mar; 232():145-154. PubMed ID: 30576770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-metastatic effect and mechanisms of Wenshen Zhuanggu Formula in human breast cancer cells.
    Han XH; Wang CL; Xie Y; Ma J; Zhang XH; Hu QW; Lin G; Liu S; Lu JG
    J Ethnopharmacol; 2015 Mar; 162():39-46. PubMed ID: 25554638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wenshen Zhuanggu formula effectively suppresses breast cancer bone metastases in a mouse Xenograft model.
    Li JJ; Chen WL; Wang JY; Hu QW; Sun ZP; Zhang S; Liu S; Han XH
    Acta Pharmacol Sin; 2017 Oct; 38(10):1369-1380. PubMed ID: 28414206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wedelolactone suppresses breast cancer growth and metastasis via regulating TGF-β1/Smad signaling pathway.
    Li H; Hou M; Zhang P; Ren L; Guo Y; Zou L; Cao J; Bai Z
    J Pharm Pharmacol; 2024 Aug; 76(8):1038-1050. PubMed ID: 38848454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydroartemisinin inhibits the tumorigenesis and metastasis of breast cancer via downregulating CIZ1 expression associated with TGF-β1 signaling.
    Li Y; Zhou X; Liu J; Gao N; Yang R; Wang Q; Ji J; Ma L; He Q
    Life Sci; 2020 May; 248():117454. PubMed ID: 32088211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TOPK promotes epithelial-mesenchymal transition and invasion of breast cancer cells through upregulation of TBX3 in TGF-β1/Smad signaling.
    Lee YJ; Park JH; Oh SM
    Biochem Biophys Res Commun; 2020 Jan; 522(1):270-277. PubMed ID: 31757421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of six coumarins in normal and breast cancer bone-metastatic mice after oral administration of Wenshen Zhuanggu Formula.
    Chen W; Li J; Sun Z; Wu C; Ma J; Wang J; Liu S; Han X
    J Ethnopharmacol; 2018 Oct; 224():36-44. PubMed ID: 29803570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wulong Xiaozheng Wan medicated serum inhibits epithelial-mesenchymal transition in human gastric carcinoma cell line BGC823 by modulation of transforming growth factor-β1/Smad signaling.
    Zhang Y; Wang B; Yang L; Li D; Yuan X; Guo X
    J Tradit Chin Med; 2019 Jun; 39(3):380-392. PubMed ID: 32186010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium.
    Yao Y; Chen R; Wang G; Zhang Y; Liu F
    Stem Cell Res Ther; 2019 Jul; 10(1):225. PubMed ID: 31358049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition.
    Sun Y; Zhou QM; Lu YY; Zhang H; Chen QL; Zhao M; Su SB
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30901941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
    Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
    Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rb2 inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling.
    Dai G; Sun B; Gong T; Pan Z; Meng Q; Ju W
    Phytomedicine; 2019 Mar; 56():126-135. PubMed ID: 30668333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
    Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
    Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
    Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
    Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
    Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shenqi detoxification granule combined with P311 inhibits epithelial-mesenchymal transition in renal fibrosis via TGF-β1-Smad-ILK pathway.
    Cai P; Liu X; Xu Y; Qi F; Si G
    Biosci Trends; 2017; 11(6):640-650. PubMed ID: 29311449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
    Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB
    Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.